Skip to main content
Arrowhead Pharmaceuticals, Inc. (LON: 0HI3)
London flag London · Delayed Price · Currency is GBP · Price in USD
19.71
+0.01 (0.05%)
Jan 22, 2025, 6:52 PM BST

Arrowhead Pharmaceuticals Revenue

In the fiscal year ending September 30, 2024, Arrowhead Pharmaceuticals had annual revenue of $3.55M USD, down -98.52%.

Revenue
$3.55M
Revenue Growth
-98.52%
P/S Ratio
n/a
Revenue / Employee
$5.83K
Employees
609
Market Cap
1.99B GBP

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Sep 30, 20243.55M-237.18M-98.52%
Sep 30, 2023240.74M-2.50M-1.03%
Sep 30, 2022243.23M104.94M75.89%
Sep 30, 2021138.29M50.30M57.16%
Sep 30, 202087.99M-80.80M-47.87%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 38.20B
GSK plc 31.31B
Haleon 11.24B
Smith & Nephew 4.46B
ConvaTec Group 1.74B
Hikma Pharmaceuticals 2.39B
HUTCHMED (China) 483.31M
Oxford Nanopore Technologies 167.75M
Revenue Rankings

Arrowhead Pharmaceuticals News

More News